[Skip to Content]
[Skip to Content Landing]

Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant PersonsUS Preventive Services Task Force Recommendation Statement

Educational Objective
To review the USPSTF recommendations regarding interventions for tobacco smoking cessation in adults.
1 Credit CME
Abstract

Importance  Tobacco use is the leading preventable cause of disease, disability, and death in the US. In 2014, it was estimated that 480 000 deaths annually are attributed to cigarette smoking, including second hand smoke exposure. Smoking during pregnancy can increase the risk of numerous adverse pregnancy outcomes (eg, miscarriage and congenital anomalies) and complications in the offspring (including sudden infant death syndrome and impaired lung function in childhood). In 2019, an estimated 50.6 million US adults (20.8% of the adult population) used tobacco; 14.0% of the US adult population currently smoked cigarettes and 4.5% of the adult population used electronic cigarettes (e-cigarettes). Among pregnant US women who gave birth in 2016, 7.2% reported smoking cigarettes while pregnant.

Objective  To update its 2015 recommendation, the USPSTF commissioned a review to evaluate the benefits and harms of primary care interventions on tobacco use cessation in adults, including pregnant persons.

Population  This recommendation statement applies to adults 18 years or older, including pregnant persons.

Evidence Assessment  The USPSTF concludes with high certainty that the net benefit of behavioral interventions and US Food and Drug Associated (FDA)–approved pharmacotherapy for tobacco smoking cessation, alone or combined, in nonpregnant adults who smoke is substantial. The USPSTF concludes with high certainty that the net benefit of behavioral interventions for tobacco smoking cessation on perinatal outcomes and smoking cessation in pregnant persons is substantial. The USPSTF concludes that the evidence on pharmacotherapy interventions for tobacco smoking cessation in pregnant persons is insufficient because few studies are available, and the balance of benefits and harms cannot be determined. The USPSTF concludes that the evidence on the use of e-cigarettes for tobacco smoking cessation in adults, including pregnant persons, is insufficient, and the balance of benefits and harms cannot be determined. The USPSTF has identified the lack of well-designed, randomized clinical trials on e-cigarettes that report smoking abstinence or adverse events as a critical gap in the evidence.

Recommendations  The USPSTF recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and FDA-approved pharmacotherapy for cessation to nonpregnant adults who use tobacco. (A recommendation) The USPSTF recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco. (A recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of e-cigarettes for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety. (I statement)

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Corresponding Author: Alex H. Krist, MD, MPH, Virginia Commonwealth University, One Capitol Square, 6th Flr, 830 E Main St, Richmond, Virginia 23219 (chair@uspstf.ne)).

Accepted for Publication: December 4, 2020.

The US Preventive Services Task Force (USPSTF) members: Alex H. Krist, MD, MPH; Karina W. Davidson, PhD, MAS; Carol M. Mangione, MD, MSPH; Michael J. Barry, MD; Michael Cabana, MD, MA, MPH; Aaron B. Caughey, MD, PhD; Katrina Donahue, MD, MPH; Chyke A. Doubeni, MD, MPH; John W. Epling Jr, MD, MSEd; Martha Kubik, PhD, RN; Gbenga Ogedegbe, MD, MPH; Lori Pbert, PhD; Michael Silverstein, MD, MPH; Melissa A. Simon, MD, MPH; Chien-Wen Tseng, MD, MPH, MSEE; John B. Wong, MD.

Affiliations of The US Preventive Services Task Force (USPSTF) members: Fairfax Family Practice Residency, Fairfax, Virginia (Krist); Virginia Commonwealth University, Richmond (Krist); Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York (Davidson); University of California, Los Angeles (Mangione); Harvard Medical School, Boston, Massachusetts (Barry); University of California, San Francisco (Cabana); Oregon Health & Science University, Portland (Caughey); University of North Carolina at Chapel Hill (Donahue); Mayo Clinic, Rochester, Minnesota (Doubeni); Virginia Tech Carilion School of Medicine, Roanoke (Epling Jr); George Mason University, Fairfax, Virginia (Kubik); New York University, New York, New York (Ogedegbe); University of Massachusetts Medical School, Worcester (Pbert); Boston University, Boston, Massachusetts (Silverstein); Northwestern University, Evanston, Illinois (Simon); University of Hawaii, Honolulu (Tseng); Pacific Health Research and Education Institute, Honolulu, Hawaii (Tseng); Tufts University School of Medicine, Boston, Massachusetts (Wong).

Author Contributions: Dr Krist had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The USPSTF members contributed equally to the recommendation statement.

Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures. All members of the USPSTF receive travel reimbursement and an honorarium for participating in USPSTF meetings. Dr Barry reported receiving grants and personal fees from Healthwise.

Funding/Support: The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.

Role of the Funder/Sponsor: AHRQ staff assisted in the following: development and review of the research plan, commission of the systematic evidence review from an Evidence-based Practice Center, coordination of expert review and public comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final recommendation statement and its submission for publication. AHRQ staff had no role in the approval of the final recommendation statement or the decision to submit for publication.

Disclaimer: Recommendations made by the USPSTF are independent of the US government. They should not be construed as an official position of AHRQ or the US Department of Health and Human Services.

Additional Contributions: We thank Tina Fan, MD, MPH (AHRQ), who contributed to the writing of the manuscript, and Lisa Nicolella, MA (AHRQ), who assisted with coordination and editing.

Additional Information: The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms.

References
1.
 The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
2.
 Women and Smoking: A Report of the Surgeon General. US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2001.
3.
 How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010.
4.
 WHO Recommendations for the Prevention and Management of Tobacco Use and Second-Hand Smoke Exposure in Pregnancy. World Health Organization; 2013.
5.
Cornelius  ME , Wang  TW , Jamal  A , Loretan  CG , Neff  LJ .  Tobacco product use among adults—United States, 2019.   MMWR Morb Mortal Wkly Rep. 2020;69(46):1736-1742. doi:10.15585/mmwr.mm6946a4PubMedGoogle ScholarCrossref
6.
Drake  P , Driscoll  AK , Mathews  TJ .  Cigarette smoking during pregnancy: United States, 2016.   NCHS Data Brief. 2018;(305):1-8.PubMedGoogle Scholar
7.
Babb  S , Malarcher  A , Schauer  G , Asman  K , Jamal  A .  Quitting smoking among adults—United States, 2000-2015.   MMWR Morb Mortal Wkly Rep. 2017;65(52):1457-1464. doi:10.15585/mmwr.mm6552a1PubMedGoogle ScholarCrossref
8.
Procedure Manual. US Preventive Services Task Force. Updated 2017. Accessed November 24, 2020. https://www.uspreventiveservicestaskforce.org/uspstf/procedure-manual
9.
Owens  DK , Davidson  KW , Krist  AH ,  et al; US Preventive Services Task Force.  Primary care interventions for prevention and cessation of tobacco use in children and adolescents: US Preventive Services Task Force recommendation statement.   JAMA. 2020;323(16):1590-1598. doi:10.1001/jama.2020.4679PubMedGoogle ScholarCrossref
10.
US Food and Drug Administration. Products, ingredients & components. Updated May 2020. Accessed November 24, 2020. https://www.fda.gov/tobacco-products/products-guidance-regulations/products-ingredients-components
11.
Centers for Disease Control and Prevention. About electronic cigarettes (e-cigarettes). Updated November 16, 2020. Accessed November 24, 2020. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/about-e-cigarettes.html
12.
Tobacco Use and Dependence Guideline Panel.  Treating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline. US Dept of Health and Human Services, Public Health Service; 2008.
13.
Patnode  CD , Henderson  JT , Melknikow  J , Coppola  EL , Durbin  S , Thomas  R .  Interventions for Tobacco Cessation in Adults, Including Pregnant Women: An Evidence Update for the U.S. Preventive Services Task Force. Evidence Synthesis No. 196. Agency for Healthcare Research and Quality; 2021. AHRQ publication 20-05264-EF-1.
14.
Patnode  CD , Henderson  JT , Melknikow  J , Coppola  EL , Durbin  S , Thomas  R .  Interventions for tobacco cessation in adults, including pregnant women: updated evidence report and systematic review for the US Preventive Services Task Force.   JAMA. Published January 19, 2021. doi:10.1001/jama.2020.23541Google Scholar
15.
Morgan  GD , Noll  EL , Orleans  CT , Rimer  BK , Amfoh  K , Bonney  G .  Reaching midlife and older smokers: tailored interventions for routine medical care.   Prev Med. 1996;25(3):346-354. doi:10.1006/pmed.1996.0065PubMedGoogle ScholarCrossref
16.
Orleans  CT , Rimer  BK , Fleisher  L .  Clear Horizons: A Quit Smoking Guide Especially for Those 50 and Over. Fox Chase Cancer Center; 1989.
17.
Canga  N , De Irala  J , Vara  E , Duaso  MJ , Ferrer  A , Martínez-González  MA .  Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings.   Diabetes Care. 2000;23(10):1455-1460. doi:10.2337/diacare.23.10.1455PubMedGoogle ScholarCrossref
18.
Glynn  TJ , Manley  MW .  How to Help Your Patients Stop Smoking: A National Cancer Institute Manual for Physicians. US Dept of Health and Human Services; 1998.
19.
Hurt  RD , Dale  LC , McClain  FL ,  et al.  A comprehensive model for the treatment of nicotine dependence in a medical setting.   Med Clin North Am. 1992;76(2):495-514. doi:10.1016/S0025-7125(16)30364-9PubMedGoogle ScholarCrossref
20.
Weissfeld  JL , Holloway  JL .  Treatment for cigarette smoking in a Department of Veterans Affairs outpatient clinic.   Arch Intern Med. 1991;151(5):973-977. doi:10.1001/archinte.1991.00400050117022PubMedGoogle ScholarCrossref
21.
 Clearing the Air: How to Quit Smoking and Quit for Keeps. National Cancer Institute; 1987.
22.
Fiore  MC , McCarthy  DE , Jackson  TC ,  et al.  Integrating smoking cessation treatment into primary care: an effectiveness study.   Prev Med. 2004;38(4):412-420. doi:10.1016/j.ypmed.2003.11.002PubMedGoogle ScholarCrossref
23.
Glasgow  RE , Whitlock  EP , Eakin  EG , Lichtenstein  E .  A brief smoking cessation intervention for women in low-income planned parenthood clinics.   Am J Public Health. 2000;90(5):786-789. doi:10.2105/AJPH.90.5.786PubMedGoogle ScholarCrossref
24.
Bock  B , Heron  K , Jennings  E ,  et al.  A text message delivered smoking cessation intervention: the initial trial of TXT-2-Quit: randomized controlled trial.   JMIR Mhealth Uhealth. 2013;1(2):e17. doi:10.2196/mhealth.2522PubMedGoogle Scholar
25.
Strecher  VJ , Rimer  BK , Monaco  KD .  Development of a new self-help guide—Freedom From Smoking for you and your family.   Health Educ Q. 1989;16(1):101–112. doi:10.1177/109019818901600111PubMedGoogle ScholarCrossref
26.
Orleans  CT , Schoenbach  VJ , Wagner  EH ,  et al.  Self-help quit smoking interventions: effects of self-help materials, social support instructions, and telephone counseling.   J Consult Clin Psychol. 1991;59(3):439-448. doi:10.1037/0022-006X.59.3.439PubMedGoogle ScholarCrossref
27.
 A Lifetime of Freedom From Smoking. American Lung Association; 1980.
28.
McBride  CM , Scholes  D , Grothaus  LC , Curry  SJ , Ludman  E , Albright  J .  Evaluation of a minimal self-help smoking cessation intervention following cervical cancer screening.   Prev Med. 1999;29(2):133-138. doi:10.1006/pmed.1999.0514PubMedGoogle ScholarCrossref
29.
Curry  SJ , McBride  C , Grothaus  LC , Louie  D , Wagner  EH .  A randomized trial of self-help materials, personalized feedback, and telephone counseling with nonvolunteer smokers.   J Consult Clin Psychol. 1995;63(6):1005-1014. doi:10.1037/0022-006X.63.6.1005PubMedGoogle ScholarCrossref
30.
Ellerbeck  EF , Mahnken  JD , Cupertino  AP ,  et al.  Effect of varying levels of disease management on smoking cessation: a randomized trial.   Ann Intern Med. 2009;150(7):437-446. doi:10.7326/0003-4819-150-7-200904070-00003PubMedGoogle ScholarCrossref
31.
McClure  JB , Westbrook  E , Curry  SJ , Wetter  DW .  Proactive, motivationally enhanced smoking cessation counseling among women with elevated cervical cancer risk.   Nicotine Tob Res. 2005;7(6):881-889. doi:10.1080/14622200500266080PubMedGoogle ScholarCrossref
32.
Rigotti  NA , Park  ER , Regan  S ,  et al.  Efficacy of telephone counseling for pregnant smokers: a randomized controlled trial.   Obstet Gynecol. 2006;108(1):83-92. doi:10.1097/01.AOG.0000218100.05601.f8PubMedGoogle ScholarCrossref
33.
Solomon  L , Quinn  V .  Spontaneous quitting: self-initiated smoking cessation in early pregnancy.   Nicotine Tob Res. 2004;6(suppl):S203-S216.Google ScholarCrossref
34.
Windsor  R , Woodby  L , Miller  T , Hardin  M .  Effectiveness of Smoking Cessation and Reduction in Pregnancy Treatment (SCRIPT) methods in Medicaid-supported prenatal care: trial III.   Health Educ Behav. 2011;38(4):412-422. doi:10.1177/1090198110382503PubMedGoogle ScholarCrossref
35.
Fiore  MB , Bailey  WC , Cohen  S ,  et al.  Smoking Cessation: Clinical Practice Guideline No. 18. Agency for Health Care Policy and Research; 1996.
36.
Windsor  RA , Cutter  G , Morris  J ,  et al.  The effectiveness of smoking cessation methods for smokers in public health maternity clinics: a randomized trial.   Am J Public Health. 1985;75(12):1389-1392. doi:10.2105/AJPH.75.12.1389PubMedGoogle ScholarCrossref
37.
Windsor  RA , Lowe  JB , Perkins  LL ,  et al.  Health education for pregnant smokers: its behavioral impact and cost benefit.   Am J Public Health. 1993;83(2):201-206. doi:10.2105/AJPH.83.2.201PubMedGoogle ScholarCrossref
38.
Windsor  R , Crawford  M , Woodby  L . Commit to Quit Smoking During and After Pregnancy. DVD. Society for Public Health Education: 1998; edited 2004.
39.
Windsor  R.   A Pregnant Woman’s Guide to Quit Smoking. Society for Public Health Education; 2005.
40.
Laine  C , Davidoff  F .  Patient-centered medicine: a professional evolution.   JAMA. 1996;275(2):152-156. doi:10.1001/jama.1996.03530260066035PubMedGoogle ScholarCrossref
41.
Bullock  L , Everett  KD , Mullen  PD , Geden  E , Longo  DR , Madsen  R .  Baby BEEP: a randomized controlled trial of nurses’ individualized social support for poor rural pregnant smokers.   Matern Child Health J. 2009;13(3):395-406. doi:10.1007/s10995-008-0363-zPubMedGoogle ScholarCrossref
42.
Lee  M , Miller  SM , Wen  KY , Hui  SK , Roussi  P , Hernandez  E .  Cognitive-behavioral intervention to promote smoking cessation for pregnant and postpartum inner city women.   J Behav Med. 2015;38(6):932-943. doi:10.1007/s10865-015-9669-7PubMedGoogle ScholarCrossref
43.
Pollak  KI , Lyna  P , Bilheimer  A ,  et al.  A pilot study testing SMS text delivered scheduled gradual reduction to pregnant smokers.   Nicotine Tob Res. 2013;15(10):1773-1776. doi:10.1093/ntr/ntt045PubMedGoogle ScholarCrossref
44.
Stotts  AL , Groff  JY , Velasquez  MM ,  et al.  Ultrasound feedback and motivational interviewing targeting smoking cessation in the second and third trimesters of pregnancy.   Nicotine Tob Res. 2009;11(8):961-968. doi:10.1093/ntr/ntp095PubMedGoogle ScholarCrossref
45.
Hoffmann  TC , Glasziou  PP , Boutron  I ,  et al.  Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.   BMJ. 2014;348:g1687. doi:10.1136/bmj.g1687PubMedGoogle ScholarCrossref
46.
US Food and Drug Administration. Want to quit smoking? FDA-approved products can help. Updated December 2017. Accessed November 24, 2020. https://www.fda.gov/consumers/consumer-updates/want-quit-smoking-fda-approved-products-can-help
47.
 Smoking Cessation. A Report of the Surgeon General. Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2020.
48.
Liu  B , Xu  G , Rong  S ,  et al.  National estimates of e-cigarette use among pregnant and nonpregnant women of reproductive age in the United States, 2014-2017.   JAMA Pediatr. 2019;173(6):600-602. doi:10.1001/jamapediatrics.2019.0658PubMedGoogle ScholarCrossref
49.
Kandra  KL , Ranney  LM , Lee  JG , Goldstein  AO .  Physicians’ attitudes and use of e-cigarettes as cessation devices, North Carolina, 2013.   PLoS One. 2014;9(7):e103462. doi:10.1371/journal.pone.0103462PubMedGoogle Scholar
50.
Ofei-Dodoo  S , Kellerman  R , Nilsen  K , Nutting  R , Lewis  D .  Family physicians’ perceptions of electronic cigarettes in tobacco use counseling.   J Am Board Fam Med. 2017;30(4):448-459. doi:10.3122/jabfm.2017.04.170084PubMedGoogle ScholarCrossref
51.
Nickels  AS , Warner  DO , Jenkins  SM , Tilburt  J , Hays  JT .  Beliefs, practices, and self-efficacy of US physicians regarding smoking cessation and electronic cigarettes: a national survey.   Nicotine Tob Res. 2017;19(2):197-207. doi:10.1093/ntr/ntw194PubMedGoogle ScholarCrossref
52.
National Academies of Sciences, Engineering, and Medicine.  Public Health Consequences of E-Cigarettes. National Academies Press; 2018.
53.
Centers for Disease Control and Prevention. Outbreak of lung injury associated with the use of e-cigarette, or vaping, products. Updated February 25, 2020. Accessed November 24, 2020. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html
54.
Wang  TW , Gentzke  AS , Creamer  MR ,  et al.  Tobacco product use and associated factors among middle and high school students—United States, 2019.   MMWR Surveill Summ. 2019;68(12):1-22. doi:10.15585/mmwr.ss6812a1PubMedGoogle ScholarCrossref
55.
Siu  AL ; US Preventive Services Task Force.  Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement.   Ann Intern Med. 2015;163(8):622-634. doi:10.7326/M15-2023PubMedGoogle ScholarCrossref
56.
Stead  LF , Buitrago  D , Preciado  N , Sanchez  G , Hartmann-Boyce  J , Lancaster  T .  Physician advice for smoking cessation.   Cochrane Database Syst Rev. 2013;5(5):CD000165.PubMedGoogle Scholar
57.
Rice  VH , Heath  L , Livingstone-Banks  J , Hartmann-Boyce  J .  Nursing interventions for smoking cessation.   Cochrane Database Syst Rev. 2017;12(12):CD001188.PubMedGoogle Scholar
58.
Lancaster  T , Stead  LF .  Individual behavioural counselling for smoking cessation.   Cochrane Database Syst Rev. 2017;3(3):CD001292.PubMedGoogle Scholar
59.
Stead  LF , Carroll  AJ , Lancaster  T .  Group behaviour therapy programmes for smoking cessation.   Cochrane Database Syst Rev. 2017;3(3):CD001007. doi:10.1002/14651858.CD001007.pub3PubMedGoogle Scholar
60.
Matkin  W , Ordóñez-Mena  JM , Hartmann-Boyce  J .  Telephone counselling for smoking cessation.   Cochrane Database Syst Rev. 2019;5(5):CD002850.PubMedGoogle Scholar
61.
Whittaker  R , McRobbie  H , Bullen  C , Rodgers  A , Gu  Y , Dobson  R .  Mobile phone text messaging and app-based interventions for smoking cessation.   Cochrane Database Syst Rev. 2019;10(10):CD006611. doi:10.1002/14651858.CD006611.pub5PubMedGoogle Scholar
62.
Hartmann-Boyce  J , Chepkin  SC , Ye  W , Bullen  C , Lancaster  T .  Nicotine replacement therapy versus control for smoking cessation.   Cochrane Database Syst Rev. 2018;5(5):CD000146. doi:10.1002/14651858.CD000146.pub5PubMedGoogle Scholar
63.
Lindson  N , Chepkin  SC , Ye  W , Fanshawe  TR , Bullen  C , Hartmann-Boyce  J .  Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.   Cochrane Database Syst Rev. 2019;4(4):CD013308. doi:10.1002/14651858.CD013308PubMedGoogle Scholar
64.
Howes  S , Hartmann-Boyce  J , Livingstone-Banks  J , Hong  B , Lindson  N .  Antidepressants for smoking cessation.   Cochrane Database Syst Rev. 2020;4(4):CD000031.PubMedGoogle Scholar
65.
Cahill  K , Lindson-Hawley  N , Thomas  KH , Fanshawe  TR , Lancaster  T .  Nicotine receptor partial agonists for smoking cessation.   Cochrane Database Syst Rev. 2016;5(5):CD006103. doi:10.1002/14651858.CD006103.pub7PubMedGoogle Scholar
66.
Stead  LF , Koilpillai  P , Fanshawe  TR , Lancaster  T .  Combined pharmacotherapy and behavioural interventions for smoking cessation.   Cochrane Database Syst Rev. 2016;3(3):CD008286. doi:10.1002/14651858.CD008286.pub3PubMedGoogle Scholar
67.
Hartmann-Boyce  J , Hong  B , Livingstone-Banks  J , Wheat  H , Fanshawe  TR .  Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.   Cochrane Database Syst Rev. 2019;6(6):CD009670. doi:10.1002/14651858.CD009670.pub4PubMedGoogle Scholar
68.
Chamberlain  C , O’Mara-Eves  A , Porter  J ,  et al.  Psychosocial interventions for supporting women to stop smoking in pregnancy.   Cochrane Database Syst Rev. 2017;2(2):CD001055. doi:10.1002/14651858.CD001055.pub5PubMedGoogle Scholar
69.
Creamer  M , Case  K , Loukas  A , Cooper  M , Perry  CL .  Patterns of sustained e-cigarette use in a sample of young adults.   Addict Behav. 2019;92:28-31. doi:10.1016/j.addbeh.2018.12.011PubMedGoogle ScholarCrossref
70.
Dai  H , Leventhal  AM .  Prevalence of e-cigarette use among adults in the United States, 2014-2018.   JAMA. 2019;322(18):1824-1827. doi:10.1001/jama.2019.15331PubMedGoogle ScholarCrossref
71.
Mirbolouk  M , Charkhchi  P , Kianoush  S ,  et al.  Prevalence and distribution of e-cigarette use among U.S. adults: Behavioral Risk Factor Surveillance System, 2016.   Ann Intern Med. 2018;169(7):429-438. doi:10.7326/M17-3440PubMedGoogle ScholarCrossref
72.
Patel  D , Davis  KC , Cox  S ,  et al.  Reasons for current E-cigarette use among U.S. adults.   Prev Med. 2016;93:14-20. doi:10.1016/j.ypmed.2016.09.011PubMedGoogle ScholarCrossref
73.
Zhuang  YL , Cummins  SE , Sun  JY , Zhu  SH .  Long-term e-cigarette use and smoking cessation: a longitudinal study with US population.   Tob Control. 2016;25(suppl 1):i90-i95. doi:10.1136/tobaccocontrol-2016-053096PubMedGoogle ScholarCrossref
74.
Wang  TW , Asman  K , Gentzke  AS ,  et al.  Tobacco product use among adults—United States, 2017.   MMWR Morb Mortal Wkly Rep. 2018;67(44):1225-1232. doi:10.15585/mmwr.mm6744a2PubMedGoogle ScholarCrossref
75.
Bullen  C , Howe  C , Laugesen  M ,  et al.  Electronic cigarettes for smoking cessation: a randomised controlled trial.   Lancet. 2013;382(9905):1629-1637. doi:10.1016/S0140-6736(13)61842-5PubMedGoogle ScholarCrossref
76.
O’Brien  B , Knight-West  O , Walker  N , Parag  V , Bullen  C .  E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial.   Tob Induc Dis. 2015;13(1):5. doi:10.1186/s12971-015-0030-2PubMedGoogle ScholarCrossref
77.
Caponnetto  P , Campagna  D , Cibella  F ,  et al.  EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study.   PLoS One. 2013;8(6):e66317. doi:10.1371/journal.pone.0066317PubMedGoogle Scholar
78.
Hajek  P , Phillips-Waller  A , Przulj  D ,  et al.  A randomized trial of e-cigarettes versus nicotine-replacement therapy.   N Engl J Med. 2019;380(7):629-637. doi:10.1056/NEJMoa1808779PubMedGoogle ScholarCrossref
79.
Walker  N , Parag  V , Verbiest  M , Laking  G , Laugesen  M , Bullen  C .  Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial.   Lancet Respir Med. 2020;8(1):54-64. doi:10.1016/S2213-2600(19)30269-3PubMedGoogle ScholarCrossref
80.
Lee  SH , Ahn  SH , Cheong  YS .  Effect of electronic cigarettes on smoking reduction and cessation in Korean male smokers: a randomized controlled study.   J Am Board Fam Med. 2019;32(4):567-574. doi:10.3122/jabfm.2019.04.180384PubMedGoogle ScholarCrossref
81.
Mills  EJ , Wu  P , Lockhart  I , Wilson  K , Ebbert  JO .  Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation: a systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals.   Tob Induc Dis. 2010;8:8. doi:10.1186/1617-9625-8-8PubMedGoogle ScholarCrossref
82.
Mills  EJ , Thorlund  K , Eapen  S , Wu  P , Prochaska  JJ .  Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.   Circulation. 2014;129(1):28-41. doi:10.1161/CIRCULATIONAHA.113.003961PubMedGoogle ScholarCrossref
83.
Hughes  JR , Stead  LF , Hartmann-Boyce  J , Cahill  K , Lancaster  T .  Antidepressants for smoking cessation.   Cochrane Database Syst Rev. 2014;1(1):CD000031.PubMedGoogle Scholar
84.
Anthenelli  RM , Benowitz  NL , West  R ,  et al.  Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.   Lancet. 2016;387(10037):2507-2520. doi:10.1016/S0140-6736(16)30272-0PubMedGoogle ScholarCrossref
85.
Benowitz  NL , Pipe  A , West  R ,  et al.  Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers: a randomized clinical trial.   JAMA Intern Med. 2018;178(5):622-631. doi:10.1001/jamainternmed.2018.0397PubMedGoogle ScholarCrossref
86.
US Food and Drug Administration. Nicotrol inhaler. Updated August 2019. Accessed November 4, 2020. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020714s018lbl.pdf
87.
US Food and Drug Administration. Highlights of prescribing information: Zyban. June 2016. Accessed November 24, 2020. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020711s044lbl.pdf
88.
US Food and Drug Administration. Highlights of prescribing information: Chantix. Updated December 2012. Accessed November 24, 2020. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021928s030lbl.pdf
89.
Blount  BC , Karwowski  MP , Shields  PG ,  et al; Lung Injury Response Laboratory Working Group.  Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI.   N Engl J Med. 2020;382(8):697-705. doi:10.1056/NEJMoa1916433PubMedGoogle ScholarCrossref
90.
Rose  G , Hamilton  PJ .  A randomised controlled trial of the effect on middle-aged men of advice to stop smoking.   J Epidemiol Community Health (1978). 1978;32(4):275-281. doi:10.1136/jech.32.4.275PubMedGoogle ScholarCrossref
91.
Rose  G , Colwell  L .  Randomised controlled trial of anti-smoking advice: final (20 year) results.   J Epidemiol Community Health. 1992;46(1):75-77. doi:10.1136/jech.46.1.75PubMedGoogle ScholarCrossref
92.
Goniewicz  ML , Smith  DM , Edwards  KC ,  et al.  Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes.   JAMA Netw Open. 2018;1(8):e185937. doi:10.1001/jamanetworkopen.2018.5937PubMedGoogle Scholar
93.
Larzelere  MM , Williams  DE .  Promoting smoking cessation.   Am Fam Physician. 2012;85(6):591-598.PubMedGoogle Scholar
94.
Patel  MS , Steinberg  MB .  In the clinic: smoking cessation.   Ann Intern Med. 2016;164(5):ITC33-ITC48. doi:10.7326/AITC201603010PubMedGoogle ScholarCrossref
95.
American College of Obstetricians and Gynecologists.  Tobacco and nicotine cessation during pregnancy: ACOG Committee Opinion, Number 807.   Obstet Gynecol. 2020;135(5):e221-e229. doi:10.1097/AOG.0000000000003822PubMedGoogle ScholarCrossref
96.
Committee on Health Care for Underserved Women.  Committee opinion number 503: tobacco use and women’s health.   Obstet Gynecol. 2011;118(3):746-750. doi:10.1097/AOG.0b013e3182310ca9PubMedGoogle ScholarCrossref
97.
Farber  HJ , Walley  SC , Groner  JA , Nelson  KE ; Section on Tobacco Control.  Clinical practice policy to protect children from tobacco, nicotine, and tobacco smoke.   Pediatrics. 2015;136(5):1008-1017. doi:10.1542/peds.2015-3110PubMedGoogle ScholarCrossref
98.
American Academy of Family Physicians. Electronic Nicotine Delivery Systems (ENDS). Acessed November 24, 2020. https://www.aafp.org/about/policies/all/electronic-nicotine-delivery-systems.html
99.
Livingston  CJ , Freeman  RJ , Costales  VC ,  et al.  Electronic nicotine delivery systems or e-cigarettes: American College of Preventive Medicine’s practice statement.   Am J Prev Med. 2019;56(1):167-178. doi:10.1016/j.amepre.2018.09.010PubMedGoogle ScholarCrossref
100.
Bhatnagar  A , Whitsel  LP , Ribisl  KM ,  et al; American Heart Association Advocacy Coordinating Committee, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research.  Electronic cigarettes: a policy statement from the American Heart Association.   Circulation. 2014;130(16):1418-1436. doi:10.1161/CIR.0000000000000107PubMedGoogle ScholarCrossref
101.
American College of Obstetricians and Gynecologists. Practice advisory: lung injury associated with e-cigarettes (“vaping”). Published October 2019. Accessed November 24, 2020. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2019/10/lung-injury-associated-with-e-cigarettes-vaping
102.
American Cancer Society. American Cancer Society Position Statement on Electronic Cigarettes. Accessed November 24, 2020. https://www.cancer.org/healthy/stay-away-from-tobacco/e-cigarettes-vaping/e-cigarette-position-statement.html
AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;;
  • 1.00 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;
  • 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program;
  • 1.00 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program; and
  • 1.00 credit toward the CME [and Self-Assessment requirements] of the American Board of Surgery’s Continuous Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.

Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close